Guardant Health Inc.
Guardant Health Inc. (GH): 1 pipeline candidate · ~57 mo cash runway · 7 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
57.4 months
D/E -11.58 · 0% dilution
N/A
1 candidate
N/A
0 buys · 43 sells (180d)
A transparent, data-derived signal for Guardant Health Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$17.0B
Cash
$1.1B
Quarterly Burn
$65.6M
Runway
57.4 mo
Revenue
$301.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| shield | — |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
484
Total value held
$11.53B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 11,553,759 | $1.07B |
| vanguard capital management llc | 11,248,360 | $1.04B |
| vanguard portfolio management llc | 5,837,992 | $539.3M |
| goldman sachs group inc | 4,435,839 | $409.7M |
| two sigma investments, lp | 4,229,531 | $390.7M |
| fmr llc | 4,116,081 | $380.2M |
| geode capital management, llc | 3,508,883 | $324.2M |
| capital international investors | 3,481,318 | $321.6M |
| franklin resources inc | 3,448,193 | $318.5M |
| deep track capital, lp | 3,338,241 | $308.4M |
Showing top 10 of 484 institutional holders of Guardant Health Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Guardant Health Inc.'s pipeline?
Guardant Health Inc. (GH) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Guardant Health Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Guardant Health Inc. has approximately 57.4 months of cash runway.
What is Guardant Health Inc.'s market capitalization?
Guardant Health Inc.'s market capitalization is approximately $17.0B.
Who is the CEO of Guardant Health Inc.?
Dr. Helmy Eltoukhy Ph.D. is the chief executive officer of Guardant Health Inc. (GH).
Get the full picture on Guardant Health Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.